Condition: Type 1 Diabetes Mellitus · Sponsor: i-SENS, Inc.
This is a prospective, single arm, open-label, interventional, pilot study to evaluate the accuracy and precision of the continuous glucose monitoring (CGM) system of i-SENS, Inc., CareSens Air 3, in adult patients with type 1 diabetes.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Headlands Research AMCR | Escondido, California, United States | Not Yet Recruiting |
| Diablo Clinical Research | Walnut Creek, California, United States | Recruiting |
| Atlanta Diabetes Associates | Atlanta, Georgia, United States | Not Yet Recruiting |
| Rainier Clinical Reseach Center | Renton, Washington, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07296276